Covid-19 (Temas de Saúde Pública)
Opinião | A COVID-19 vai continuar, mas o fim da pandemia está próximo.
21 Jan, 2022 | 16:02hCOVID-19 will continue but the end of the pandemic is near – The Lancet
Comentário no Twitter
.@IHME_UW's Chris Murray predicting the end of the pandemic is nigh
"More than 50% of the world will have been infected with omicron …[by] the end of March, 2022"
"After the omicron wave, COVID-19 will return but the pandemic will not."https://t.co/9NSw8lZuUe @TheLancet— Eric Topol (@EricTopol) January 20, 2022
Opinião | Agora que a ciência já tornou a Covid menos grave, é hora de seguirmos com nossas vidas.
21 Jan, 2022 | 16:01hNow that science has defanged Covid, it’s time to get on with our lives – The Guardian
Ver também: A National Strategy for the “New Normal” of Life With COVID – JAMA
Europa considera uma nova estratégia contra COVID-19: aceitar o vírus.
21 Jan, 2022 | 16:00hEurope considers new COVID-19 strategy: Accepting the virus – Associated Press
Estudo randomizado | Imunogenicidade e reatogenicidade de diferentes vacinas de reforço após a primeira dose da vacina da J&J.
21 Jan, 2022 | 15:58h
Comentário no Twitter
Trial examined effects of boosting with one of the three approved #COVI19 vaccines — AD26.COV2.S, mRNA-1273, or BNT162b2 — 3 mos after the primary vaccination. All increased neutralizing-antibody levels & T-cell responses; mRNA vaccines were higher. https://t.co/qkpQFvNliJ pic.twitter.com/MUfa1OEsLP
— NEJM (@NEJM) January 19, 2022
[Preprint] Gravidade da infecção por COVID em crianças com menos de 5 anos antes e depois do surgimento da variante Ômicron nos EUA.
21 Jan, 2022 | 15:54hComentário: SARS-CoV-2 Omicron infections milder in children compared to Delta – News Medical
Grupo de especialistas em emergências da OMS reafirma posição contra os “passaportes de vacina” para viagens internacionais.
21 Jan, 2022 | 15:53hEditorial | Vacinas contra Covid-19 e tratamentos: devemos ter os dados brutos, agora.
21 Jan, 2022 | 15:52hCovid-19 vaccines and treatments: we must have raw data, now – The BMJ
Comunicado de imprensa: Editors call for covid-19 vaccine and treatment data to be available for public scrutiny – The BMJ
Longevidade do reforço: dados revelam quanto tempo dura a proteção da terceira dose.
20 Jan, 2022 | 23:19hBooster longevity: Data reveals how long a third shot protects – NPR
Relatório original: SARS-CoV-2 variants of concern and variants under investigation in England – U.K. Health Security Agency
Estudo de coorte retrospectiva de base populacional no Catar mostrou menor risco de infecção por Covid-19 após a vacina da Moderna em comparação com a da Pfizer–BioNTech.
20 Jan, 2022 | 23:17hEffectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar – New England Journal of Medicine
Comentário no Twitter
In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273, both were highly effective at preventing hospitalization & death. Breakthrough infections were lower among those who received mRNA-1273 than those who received BNT162b2. https://t.co/wgkrzfLNHz pic.twitter.com/E8hXIDFqWW
— NEJM (@NEJM) January 19, 2022
Depois da Ômicron, poderíamos ter uma pausa. Talvez tenhamos.
20 Jan, 2022 | 23:10hAfter Omicron, we could use a break. We may just get it – STAT